L

Longeveron
D

LGVN

1.54000
USD
-0.10
(-6.10%)
مغلق
حجم التداول
1,552
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
22,848,634
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AMC
    -0.06100
    (-1.75%)
    3.43000 USD
    B
    BB
    -0.34000
    (-6.09%)
    5.24500 USD
    G
    GME
    -0.600
    (-2.22%)
    26.430 USD
    N
    NOK
    -0.04500
    (-0.90%)
    4.94000 USD
    R
    RKT
    0.520
    (4.08%)
    13.250 USD
    S
    SNDL
    0.00500
    (0.28%)
    1.77000 USD
    المزيد
الأخبار
المقالات

العنوان: Longeveron

القطاع: Healthcare
الصناعة: Biotechnology
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.